These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 29584547)
1. Molecular Characterization and Mortality From Breast Cancer in Men. Massarweh SA; Sledge GW; Miller DP; McCullough D; Petkov VI; Shak S J Clin Oncol; 2018 May; 36(14):1396-1404. PubMed ID: 29584547 [TBL] [Abstract][Full Text] [Related]
2. Distribution of 21-Gene Recurrence Scores in Male Breast Cancer in the United States. Altman AM; Kizy S; Yuan J; Denbo JW; Jensen EH; Hui JYC; Tuttle TM; Marmor S Ann Surg Oncol; 2018 Aug; 25(8):2296-2302. PubMed ID: 29907942 [TBL] [Abstract][Full Text] [Related]
3. The Prognostic Significance of the Oncotype DX Recurrence Score in T Wang M; Wu K; Zhang P; Zhang M; Ding A; Chen H Ann Surg Oncol; 2019 May; 26(5):1227-1235. PubMed ID: 30456680 [TBL] [Abstract][Full Text] [Related]
4. Predictors for Survival and Distribution of 21-Gene Recurrence Score in Patients With Pure Mucinous Breast Cancer: A SEER Population-Based Retrospective Analysis. Ding S; Wu J; Lin C; Chen W; Li Y; Shen K; Zhu L Clin Breast Cancer; 2019 Feb; 19(1):e66-e73. PubMed ID: 30396812 [TBL] [Abstract][Full Text] [Related]
5. Sex Disparity Observed for Oncotype DX Breast Recurrence Score in Predicting Mortality Among Patients with Early Stage ER-Positive Breast Cancer. Wang F; Reid S; Zheng W; Pal T; Meszoely I; Mayer IA; Bailey CE; Park BH; Shu XO Clin Cancer Res; 2020 Jan; 26(1):101-109. PubMed ID: 31748278 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy and survival among patients 70 years of age and younger with node-negative breast cancer and the 21-gene recurrence score of 26-30. Park S; Han Y; Liu Y; Toriola AT; Peterson LL; Colditz GA; Kim SI; Cho YU; Park BW; Park Y Breast Cancer Res; 2019 Oct; 21(1):110. PubMed ID: 31619259 [TBL] [Abstract][Full Text] [Related]
7. Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database. Roberts MC; Miller DP; Shak S; Petkov VI Breast Cancer Res Treat; 2017 Jun; 163(2):303-310. PubMed ID: 28243896 [TBL] [Abstract][Full Text] [Related]
8. Clinicopathological characteristics, practical treatments, prognosis, and clinical issues of older breast cancer patients in Japan. Sawaki M; Yamada A; Kumamaru H; Miyata H; Nakayama K; Shimizu C; Miyashita M; Honma N; Taira N; Saji S Breast Cancer; 2021 Jan; 28(1):1-8. PubMed ID: 33219915 [TBL] [Abstract][Full Text] [Related]
9. 21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology. Mamounas EP; Tang G; Paik S; Baehner FL; Liu Q; Jeong JH; Kim SR; Butler SM; Jamshidian F; Cherbavaz DB; Sing AP; Shak S; Julian TB; Lembersky BC; Lawrence Wickerham D; Costantino JP; Wolmark N Breast Cancer Res Treat; 2018 Feb; 168(1):69-77. PubMed ID: 29128898 [TBL] [Abstract][Full Text] [Related]
10. Predictive of 21-gene recurrence score assay in non-estrogen receptor-positive and lymph node-negative breast cancer. Lu K; Li H; Wu Z; Liu D; Ye H; Xu L; Liu Y J BUON; 2018; 23(5):1297-1301. PubMed ID: 30570850 [TBL] [Abstract][Full Text] [Related]
11. Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study. Wei JL; Zhang JX; Fu DY World J Surg Oncol; 2018 Dec; 16(1):236. PubMed ID: 30558615 [TBL] [Abstract][Full Text] [Related]
12. Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancer. Mutonga M; Speedy S; Rademaker A; Liu D; Uthe R; Jain S; Gradishar WJ; Flaum L; Santa-Maria CA Breast Cancer Res Treat; 2019 Jul; 176(1):95-100. PubMed ID: 30977026 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological Characteristics and Breast Cancer-Specific Survival of Patients With Single Hormone Receptor-Positive Breast Cancer. Li Y; Yang D; Yin X; Zhang X; Huang J; Wu Y; Wang M; Yi Z; Li H; Li H; Ren G JAMA Netw Open; 2020 Jan; 3(1):e1918160. PubMed ID: 31899528 [TBL] [Abstract][Full Text] [Related]
14. Impact of Breast Cancer Subtypes on Prognosis of Women with Operable Invasive Breast Cancer: A Population-based Study Using SEER Database. Hwang KT; Kim J; Jung J; Chang JH; Chai YJ; Oh SW; Oh S; Kim YA; Park SB; Hwang KR Clin Cancer Res; 2019 Mar; 25(6):1970-1979. PubMed ID: 30559169 [TBL] [Abstract][Full Text] [Related]
15. 21-gene recurrence score testing in the older population with estrogen receptor-positive breast cancer. Kizy S; Altman AM; Marmor S; Denbo JW; Jensen EH; Tuttle TM; Hui JYC J Geriatr Oncol; 2019 Mar; 10(2):322-329. PubMed ID: 30093354 [TBL] [Abstract][Full Text] [Related]
16. Oncotype DX in Bilateral Synchronous Primary Invasive Breast Cancer. Karsten M; Stempel M; Radosa J; Patil S; King TA Ann Surg Oncol; 2016 Feb; 23(2):471-6. PubMed ID: 26340863 [TBL] [Abstract][Full Text] [Related]
17. Effects of marital status on breast cancer survival by age, race, and hormone receptor status: A population-based Study. Zhai Z; Zhang F; Zheng Y; Zhou L; Tian T; Lin S; Deng Y; Xu P; Hao Q; Li N; Yang P; Li H; Dai Z Cancer Med; 2019 Aug; 8(10):4906-4917. PubMed ID: 31267686 [TBL] [Abstract][Full Text] [Related]
18. Association of LN Evaluation with Survival in Women Aged 70 Years or Older With Clinically Node-Negative Hormone Receptor Positive Breast Cancer. Chagpar AB; Hatzis C; Pusztai L; DiGiovanna MP; Moran M; Mougalian S; Sanft T; Evans S; Hofstatter E; Wilson LD; Lannin DR Ann Surg Oncol; 2017 Oct; 24(10):3073-3081. PubMed ID: 28766195 [TBL] [Abstract][Full Text] [Related]
19. Impact of the 21-gene recurrence score on outcome in patients with invasive lobular carcinoma of the breast. Kizy S; Huang JL; Marmor S; Tuttle TM; Hui JYC Breast Cancer Res Treat; 2017 Oct; 165(3):757-763. PubMed ID: 28647915 [TBL] [Abstract][Full Text] [Related]